Northern Trust’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q4 | – | Sell |
-1,250,239
| Closed | -$4.25M | – | 4344 |
|
2018
Q3 | $4.25M | Buy |
1,250,239
+60,096
| +5% | +$204K | ﹤0.01% | 2779 |
|
2018
Q2 | $4.48M | Buy |
1,190,143
+96,580
| +9% | +$363K | ﹤0.01% | 2736 |
|
2018
Q1 | $4.47M | Sell |
1,093,563
-10,485
| -0.9% | -$42.9K | ﹤0.01% | 2649 |
|
2017
Q4 | $5.13M | Sell |
1,104,048
-26,873
| -2% | -$125K | ﹤0.01% | 2588 |
|
2017
Q3 | $8.03M | Buy |
1,130,921
+41,061
| +4% | +$292K | ﹤0.01% | 2331 |
|
2017
Q2 | $7.88M | Buy |
1,089,860
+70,420
| +7% | +$509K | ﹤0.01% | 2320 |
|
2017
Q1 | $6.28M | Buy |
1,019,440
+62,298
| +7% | +$384K | ﹤0.01% | 2417 |
|
2016
Q4 | $5.61M | Buy |
957,142
+4,926
| +0.5% | +$28.9K | ﹤0.01% | 2474 |
|
2016
Q3 | $5.06M | Sell |
952,216
-2,181
| -0.2% | -$11.6K | ﹤0.01% | 2511 |
|
2016
Q2 | $6.32M | Sell |
954,397
-216,130
| -18% | -$1.43M | ﹤0.01% | 2313 |
|
2016
Q1 | $5.47M | Buy |
1,170,527
+11,109
| +1% | +$51.9K | ﹤0.01% | 2355 |
|
2015
Q4 | $5.86M | Buy |
1,159,418
+28,344
| +3% | +$143K | ﹤0.01% | 2369 |
|
2015
Q3 | $3.98M | Buy |
1,131,074
+30,590
| +3% | +$108K | ﹤0.01% | 2584 |
|
2015
Q2 | $11M | Sell |
1,100,484
-13,240
| -1% | -$132K | ﹤0.01% | 2008 |
|
2015
Q1 | $14.2M | Buy |
1,113,724
+106,351
| +11% | +$1.35M | ﹤0.01% | 1843 |
|
2014
Q4 | $14.3M | Sell |
1,007,373
-34,369
| -3% | -$486K | ﹤0.01% | 1793 |
|
2014
Q3 | $14.3M | Sell |
1,041,742
-2,089
| -0.2% | -$28.7K | ﹤0.01% | 1775 |
|
2014
Q2 | $16.1M | Sell |
1,043,831
-124,747
| -11% | -$1.92M | 0.01% | 1701 |
|
2014
Q1 | $19.9M | Buy |
1,168,578
+5,035
| +0.4% | +$85.8K | 0.01% | 1572 |
|
2013
Q4 | $15.1M | Buy |
1,163,543
+26,091
| +2% | +$338K | ﹤0.01% | 1768 |
|
2013
Q3 | $11.5M | Sell |
1,137,452
-5,898
| -0.5% | -$59.5K | ﹤0.01% | 1930 |
|
2013
Q2 | $8.54M | Buy |
+1,143,350
| New | +$8.54M | ﹤0.01% | 2036 |
|